Ricard Navinés, PhD
- 4Articles
- 19.5KReads1
- 2009–2014Active
- 29Collaborators
- 357Citations2
About
Ricard Navinés, PhD, has published extensively on the intersection of hepatitis C and depression, focusing on interferon-induced depressive symptoms and their prophylactic treatment. His work includes systematic reviews, meta-analyses, and clinical trials investigating antidepressant interventions, such as escitalopram, for managing depression related to pegylated interferon alfa-2a therapy. Navinés's research also explores the role of personality factors in depression among patients undergoing antiviral treatment.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
